- Home
- MGRX vs IMCC Comparison
MGRX vs IMCC Comparison
Compare MGRX & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGRX | IMCC |
|---|---|---|
| Founded | 2021 | 1980 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 7.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MGRX | IMCC |
|---|---|---|
| Price | $0.38 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 355.7K | 59.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.90 |
| 52 Week High | $6.15 | $7.12 |
Technical Indicators
Market Signals| Indicator | MGRX | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 33.55 | 32.63 |
| Support Level | $0.36 | $0.90 |
| Resistance Level | $0.45 | $1.24 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 26.56 | 28.73 |
Price Performance
Historical ComparisonAbout MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.